We are a physician-led, integrated global oncology company. Our goal is to unveil the complex mechanisms of cancer, in order to support precision oncology. Only a multi-omics approach can achieve this goal – and reliable multi-omics require especially high-quality biospecimens and data.

Through our three divisions, IndivuServ, IndivuType, and IndivuTest
we offer specialized products and services that support our customers in biomarker and target discovery, drug development, clinical trials, individualized therapy and more.